Cost Sharing – A Closer Look Reveals Unintended Consequences

Recently the NY Times had an article commenting on the unforeseen consequences of cost-sharing among patients with chronic illnesses like diabetes, hypertension, and heart disease. This is based on a recent study from The National Bureau of Economic Research that observed patients with higher cost-sharing for medications tend to cut back on them which can have deleterious consequences – more ER visits, hospitalizations, and complications from their chronic illnesses. This would then lead to more healthcare spending which is what cost-sharing was meant to decrease. Check out the article below and click on the link above to the study!

With Sickest Patients, Cost Sharing Comes At A Price